Workflow
机构风向标 | 辰欣药业(603367)2025年二季度已披露前十大机构累计持仓占比54.15%

Group 1 - The core viewpoint of the news is that Chenxin Pharmaceutical (603367.SH) has reported significant institutional investment, with 17 institutional investors holding a total of 246 million shares, representing 54.39% of the company's total equity as of August 27, 2025 [1] - The top ten institutional investors collectively hold 54.15% of the shares, with an increase of 2.08 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, four new public funds have been disclosed this period, including Rongtong Health Industry Flexible Allocation Mixed A/B and others [2] - Four public funds were not disclosed in this period compared to the previous quarter, including Dachen Multi-Strategy Mixed (LOF) A and others [2]